Total Payments
$8,986
2024 Payments
$1,155
Companies
43
Transactions
528
Medicare Patients
13,073
Medicare Billing
$856,111
Payment Breakdown by Category
Food & Beverage$8,978 (99.9%)
Education$7.90 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,978 | 526 | 99.9% |
| Education | $7.90 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,140 | 58 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,111 | 75 | $0 (2024) |
| Novo Nordisk Inc | $961.09 | 68 | $0 (2024) |
| Lilly USA, LLC | $569.35 | 32 | $0 (2024) |
| GlaxoSmithKline, LLC. | $540.82 | 28 | $0 (2024) |
| PFIZER INC. | $530.28 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $493.65 | 29 | $0 (2023) |
| Allergan, Inc. | $347.08 | 22 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $305.42 | 16 | $0 (2024) |
| Amgen Inc. | $289.05 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,155 | 64 | ABBVIE INC. ($246.11) |
| 2023 | $1,621 | 90 | ABBVIE INC. ($301.20) |
| 2022 | $1,660 | 92 | ABBVIE INC. ($233.41) |
| 2021 | $1,281 | 73 | AbbVie Inc. ($264.91) |
| 2020 | $1,165 | 73 | Allergan, Inc. ($202.62) |
| 2019 | $926.44 | 60 | AstraZeneca Pharmaceuticals LP ($181.57) |
| 2018 | $599.61 | 39 | AstraZeneca Pharmaceuticals LP ($183.07) |
| 2017 | $578.73 | 37 | AstraZeneca Pharmaceuticals LP ($157.24) |
All Payment Transactions
528 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Obesity | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Obesity | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: VACCINES | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/06/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Oncology | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Gastroenterology | ||||||
| 09/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: DIABETES | ||||||
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: PAIN | ||||||
| 08/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,720 | 5,283 | $501,812 | $272,101 |
| 2022 | 30 | 3,417 | 4,632 | $425,667 | $224,788 |
| 2021 | 28 | 3,234 | 4,470 | $393,048 | $207,432 |
| 2020 | 29 | 2,702 | 3,680 | $331,549 | $151,789 |
Total Patients
13,073
Total Services
18,065
Medicare Billing
$856,111
Procedure Codes
115
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 564 | 1,388 | $189,010 | $89,917 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 282 | 518 | $85,650 | $49,803 | 58.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 357 | 357 | $89,250 | $49,241 | 55.2% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 201 | 201 | $19,729 | $12,401 | 62.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 44 | 44 | $12,550 | $11,955 | 95.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 90 | 90 | $18,360 | $7,241 | 39.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 316 | 316 | $9,480 | $6,222 | 65.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 87 | 87 | $6,240 | $5,949 | 95.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 299 | 299 | $8,970 | $5,944 | 66.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $11,300 | $4,851 | 42.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 80 | 161 | $4,947 | $4,317 | 87.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 359 | 403 | $9,794 | $4,045 | 41.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $4,750 | $3,357 | 70.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 108 | 108 | $3,240 | $3,088 | 95.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 114 | 126 | $5,386 | $2,412 | 44.8% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 44 | 76 | $1,943 | $1,905 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 52 | 54 | $3,240 | $1,732 | 53.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 337 | 479 | $3,352 | $1,627 | 48.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 47 | 47 | $1,410 | $1,382 | 98.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 26 | 29 | $4,350 | $1,004 | 23.1% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 92 | 212 | $1,484 | $808.50 | 54.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 17 | $1,020 | $759.05 | 74.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 59 | $1,770 | $668.75 | 37.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 35 | 36 | $720.00 | $583.20 | 81.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 21 | 21 | $1,050 | $388.74 | 37.0% |
About Dr. Francesca Hilmi, DO
Dr. Francesca Hilmi, DO is a Family Medicine healthcare provider based in Kingston, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891774998.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francesca Hilmi, DO has received a total of $8,986 in payments from pharmaceutical and medical device companies, with $1,155 received in 2024. These payments were reported across 528 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($8,978).
As a Medicare-enrolled provider, Hilmi has provided services to 13,073 Medicare beneficiaries, totaling 18,065 services with total Medicare billing of $856,111. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Kingston, NY
- Active Since 01/17/2006
- Last Updated 10/01/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891774998
Products in Payments
- FARXIGA (Drug) $807.97
- UBRELVY (Drug) $548.08
- Ozempic (Drug) $432.16
- QULIPTA (Drug) $390.82
- XARELTO (Drug) $384.21
- NURTEC ODT (Drug) $348.85
- MOUNJARO (Drug) $346.38
- TRELEGY ELLIPTA (Drug) $336.57
- VRAYLAR (Drug) $274.73
- Saxenda (Drug) $252.07
- XIFAXAN (Drug) $241.49
- Kerendia (Drug) $227.19
- ELIQUIS (Drug) $208.31
- JARDIANCE (Drug) $202.89
- ENTRESTO (Drug) $198.02
- UNITHROID (Drug) $188.72
- Vascepa (Drug) $182.91
- Otezla (Drug) $150.30
- Rybelsus (Drug) $137.84
- PREVNAR 20 (Biological) $133.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kingston
Dr. Bhavana Vora, M.d, M.D
Family Medicine — Payments: $26,080
Family Medicine $26,080
Dr. Anthony Giardina, Do, DO
Family Medicine — Payments: $18,643
Family Medicine $18,643
Dr. Elizabeth Costley, Do, DO
Family Medicine — Payments: $14,780
Family Medicine $14,780
Dr. Ira Vohra, M.d, M.D
Family Medicine — Payments: $9,915
Family Medicine $9,915
Louise Breakstone, M.d, M.D
Family Medicine — Payments: $7,830
Family Medicine $7,830
Dr. Pal Lekaj, Md, MD
Family Medicine — Payments: $5,463
Family Medicine $5,463